<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Inpatient Antibiotic Guide</title>
<style>
  body { font-family: Arial, sans-serif; margin: 0; display: flex; height: 100vh; }
  #sidebar { width: 250px; background: #2c3e50; color: white; padding: 20px; overflow-y: auto; }
  #sidebar h2 { margin-top: 0; }
  #sidebar ul { list-style: none; padding-left: 0; }
  #sidebar li { padding: 10px; cursor: pointer; border-radius: 5px; }
  #sidebar li:hover { background-color: #34495e; }
  #content { flex-grow: 1; padding: 20px; overflow-y: auto; }
  h1, h2, h3 { margin-top: 0.5em; }
  table { border-collapse: collapse; width: 100%; margin-bottom: 20px; }
  th, td { border: 1px solid #bdc3c7; padding: 8px; text-align: left; }
  th { background-color: #ecf0f1; }
  .expandable { cursor: pointer; color: #2980b9; margin: 10px 0; }
  .hidden { display: none; }
  .firstline { background-color: #dff0d8; }
  .alternative { background-color: #fcf8e3; }
  .caution { background-color: #f2dede; }
</style>
</head>
<body>

<div id="sidebar">
  <h2>Infections</h2>
  <ul>
    <li onclick="showContent('cap')">Community-Acquired Pneumonia</li>
    <li onclick="showContent('hap')">Hospital-Acquired Pneumonia</li>
    <li onclick="showContent('uti')">Urinary Tract Infection</li>
    <li onclick="showContent('ssi')">Skin & Soft Tissue Infection</li>
    <li onclick="showContent('iab')">Intra-Abdominal Infection</li>
    <li onclick="showContent('cns')">CNS Infection</li>
    <li onclick="showContent('endocarditis')">Endocarditis</li>
  </ul>
</div>

<div id="content">
  <h1>Welcome to the Inpatient Antibiotic Guide</h1>
  <p>Select an infection from the sidebar to view empiric therapy, Gram-stain guidance, culture-directed therapy, and references.</p>
</div>

<script>
  const contentData = {
    cap: `
      <h2>Community-Acquired Pneumonia (CAP)</h2>
      <h3>Empiric Therapy</h3>
      <table>
        <tr><th>Drug</th><th>Dose</th><th>Notes</th><th>References</th></tr>
        <tr class="firstline"><td>Amoxicillin</td><td>1 g PO TID</td><td>First-line for non-severe CAP</td><td>IDSA 2019, NEJM 2021</td></tr>
        <tr class="alternative"><td>Doxycycline</td><td>100 mg PO BID</td><td>Alternative if penicillin allergy</td><td>IDSA 2019</td></tr>
        <tr class="alternative"><td>Azithromycin</td><td>500 mg PO Day 1, then 250 mg daily x4d</td><td>Macrolide monotherapy for healthy outpatient</td><td>IDSA 2019</td></tr>
      </table>

      <div class="expandable" onclick="toggleVisibility('capGram')">Gram-Stain Guidance</div>
      <div id="capGram" class="hidden">
        <ul>
          <li>Gram-positive cocci in pairs → Streptococcus pneumoniae coverage</li>
          <li>Gram-negative rods → Consider broad-spectrum coverage (e.g., cefepime, piperacillin-tazobactam)</li>
          <li>MRSA suspected → Add vancomycin or linezolid</li>
        </ul>
      </div>

      <div class="expandable" onclick="toggleVisibility('capCulture')">Culture-Directed Therapy</div>
      <div id="capCulture" class="hidden">
        <table>
          <tr><th>Pathogen</th><th>Drug</th><th>Dose</th><th>Duration</th><th>References</th></tr>
          <tr><td>Streptococcus pneumoniae</td><td>Penicillin G / Ceftriaxone</td><td>Pen G 2M units IV q4h, Ceftriaxone 1g IV daily</td><td>5–7 days</td><td>IDSA 2019</td></tr>
          <tr><td>MRSA</td><td>Vancomycin / Linezolid</td><td>Vanc 15 mg/kg IV q12h, Linezolid 600 mg PO/IV q12h</td><td>7–14 days</td><td>IDSA 2019</td></tr>
          <tr><td>Pseudomonas aeruginosa</td><td>Cefepime / Piperacillin-tazobactam</td><td>Cefepime 2g IV q8h, PIP-TAZO 4.5g IV q6h</td><td>7–10 days</td><td>IDSA 2019</td></tr>
        </table>
      </div>

      <h3>Special Considerations</h3>
      <ul>
        <li>Renal/hepatic impairment → adjust dosing</li>
        <li>Immunocompromised patients may require broader coverage</li>
        <li>Allergies → select alternatives (e.g., doxycycline, levofloxacin)</li>
      </ul>

      <h3>References</h3>
      <ul>
        <li>IDSA Guidelines 2019</li>
        <li>NEJM Clinical Review 2021</li>
        <li>Harrison's Principles of Internal Medicine, 20th Edition</li>
      </ul>
    `,

    hap: `
      <h2>Hospital-Acquired Pneumonia (HAP)</h2>
      <h3>Empiric Therapy</h3>
      <table>
        <tr><th>Drug</th><th>Dose</th><th>Notes</th><th>References</th></tr>
        <tr class="firstline"><td>Vancomycin</td><td>15 mg/kg IV q12h</td><td>MRSA coverage</td><td>IDSA 2016</td></tr>
        <tr class="firstline"><td>Piperacillin-Tazobactam</td><td>4.5 g IV q6h</td><td>Gram-negative coverage including Pseudomonas</td><td>IDSA 2016</td></tr>
      </table>

      <div class="expandable" onclick="toggleVisibility('hapGram')">Gram-Stain Guidance</div>
      <div id="hapGram" class="hidden">
        <ul>
          <li>Gram-positive cocci → MRSA coverage</li>
          <li>Gram-negative rods → Continue broad-spectrum beta-lactam</li>
        </ul>
      </div>

      <div class="expandable" onclick="toggleVisibility('hapCulture')">Culture-Directed Therapy</div>
      <div id="hapCulture" class="hidden">
        <table>
          <tr><th>Pathogen</th><th>Drug</th><th>Dose</th><th>Duration</th><th>References</th></tr>
          <tr><td>MRSA</td><td>Vancomycin / Linezolid</td><td>Vanc 15 mg/kg IV q12h, Linezolid 600 mg IV/PO q12h</td><td>7–14 days</td><td>IDSA 2016</td></tr>
          <tr><td>Pseudomonas</td><td>Cefepime / Piperacillin-tazobactam / Meropenem</td><td>Standard IV dosing per IDSA</td><td>7–10 days</td><td>IDSA 2016</td></tr>
        </table>
      </div>
    `,

    uti: `
      <h2>Urinary Tract Infection (UTI)</h2>
      <h3>Empiric Therapy</h3>
      <table>
        <tr><th>Drug</th><th>Dose</th><th>Notes</th><th>References</th></tr>
        <tr class="firstline"><td>Ceftriaxone</td><td>1 g IV daily</td><td>Uncomplicated inpatient UTI</td><td>IDSA 2019</td></tr>
        <tr class="alternative"><td>Ciprofloxacin</td><td>400 mg IV q12h</td><td>Alternative for allergy or resistant pathogen</td><td>IDSA 2019</td></tr>
      </table>

      <div class="expandable" onclick="toggleVisibility('utiGram')">Gram-Stain Guidance</div>
      <div id="utiGram" class="hidden">
        <ul>
          <li>Gram-negative rods → Continue broad-spectrum coverage (E. coli, Klebsiella)</li>
          <li>Gram-positive cocci → Consider Enterococcus coverage</li>
        </ul>
      </div>
    `,

    ssi: `
      <h2>Skin & Soft Tissue Infection (SSI)</h2>
      <h3>Empiric Therapy</h3>
      <table>
        <tr><th>Drug</th><th>Dose</th><th>Notes</th><th>References</th></tr>
        <tr class="firstline"><td>Cephalexin</td><td>500 mg PO QID</td><td>Mild infection</td><td>IDSA 2014</td></tr>
        <tr class="alternative"><td>Clindamycin</td><td>300 mg PO TID</td><td>Allergy alternative</td><td>IDSA 2014</td></tr>
        <tr class="caution"><td>Vancomycin</td><td>15 mg/kg IV q12h</td><td>Severe or MRSA risk</td><td>IDSA 2014</td></tr>
      </table>
    `,

    iab: `
      <h2>Intra-Abdominal Infection (IAI)</h2>
      <p>Empiric therapy depends on severity and community vs hospital-acquired; often includes broad-spectrum beta-lactams ± metronidazole. Customize per culture results.</p>
    `,

    cns: `
      <h2>CNS Infection</h2>
      <p>Empiric therapy guided by age, immunocompetence, and risk factors. Includes vancomycin + ceftriaxone ± ampicillin for Listeria. Adjust based on CSF Gram stain and cultures.</p>
    `,

    endocarditis: `
      <h2>Endocarditis</h2>
      <p>Empiric therapy: Vancomycin ± gentamicin until blood culture results. Adjust therapy based on Gram stain, culture, and organism susceptibility.</p>
    `
  };

  function showContent(infection) {
    document.getElementById('content').innerHTML = contentData[infection];
  }

  function toggleVisibility(id) {
    const elem = document.getElementById(id);
    elem.classList.toggle('hidden');
  }
</script>

</body>
</html>
